A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Insulin detemir
Etorphine
The risk or severity of serotonin syndrome can be increased when Etorphine is combined with Levomilnacipran.
Insulin detemir
Ethylmorphine
The risk or severity of serotonin syndrome can be increased when Ethylmorphine is combined with Levomilnacipran.
Insulin detemir
Diamorphine
The risk or severity of serotonin syndrome can be increased when Diamorphine is combined with Levomilnacipran.
Insulin detemir
Dihydroetorphine
The risk or severity of serotonin syndrome can be increased when Dihydroetorphine is combined with Levomilnacipran.
Insulin detemir
Methadyl acetate
The risk or severity of serotonin syndrome can be increased when Methadyl acetate is combined with Levomilnacipran.
Insulin detemir
Tedizolid phosphate
The risk or severity of serotonin syndrome can be increased when Tedizolid phosphate is combined with Levomilnacipran.
Insulin detemir
Acetyldigoxin
The risk or severity of hypotension can be increased when Levomilnacipran is combined with Acetyldigoxin.
Insulin detemir
Metildigoxin
The risk or severity of hypotension can be increased when Levomilnacipran is combined with Metildigoxin.
Insulin detemir
Midostaurin
The metabolism of Levomilnacipran can be decreased when combined with Midostaurin.
Insulin detemir
Troleandomycin
The metabolism of Levomilnacipran can be decreased when combined with Troleandomycin.
Insulin detemir
Danoprevir
The metabolism of Levomilnacipran can be decreased when combined with Danoprevir.
Insulin detemir
Ribociclib
The metabolism of Levomilnacipran can be decreased when combined with Ribociclib.
Insulin detemir
Stiripentol
The metabolism of Levomilnacipran can be decreased when combined with Stiripentol.
Insulin detemir
Elvitegravir
The metabolism of Levomilnacipran can be decreased when combined with Elvitegravir.
Insulin detemir
Cobicistat
The metabolism of Levomilnacipran can be decreased when combined with Cobicistat.
Insulin detemir
Ditiocarb
The metabolism of Levomilnacipran can be decreased when combined with Ditiocarb.
Insulin detemir
Tapentadol
Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Levomilnacipran.
Insulin detemir
Suvorexant
Levomilnacipran may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Insulin detemir
Sodium oxybate
Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Levomilnacipran.
Insulin detemir
Rufinamide
The risk or severity of adverse effects can be increased when Rufinamide is combined with Levomilnacipran.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3